United States Government Publishing Office publisher pbl distributor dst United States National Archives and Records Administration Office of the Federal Register author aut Government Organization text government publication eng FR Regulatory Information 2017_register executive 2017-02-27 article Rules and Regulations D09002ee1c7f290b3 D09002ee1c7f2910d United States Department of Health and Human Services originator org United States Government Agency or Subagency United States Food and Drug Administration originator org United States Government Agency or Subagency In accordance with a determination by the Director of the Office of Management and Budget (OMB) that the direct final rule ("Use of Ozone Depleting Substances") published on October 26, 2016, is excluded from the memorandum of January 20, 2017, from the Assistant to the President and Chief of Staff, entitled "Regulatory Freeze Pending Review," this action confirms the effective date of February 23, 2017, for the direct final rule. 82 FR 12067 https://www.govinfo.gov/app/details/FR-2017-02-28/2017-03866 2017-03866 fr28fe17-4 RIN 0910-AH36 4164-01-P Docket No. FDA-2015-N-1355 https://www.govinfo.gov/app/details/FR-2017-02-28/2017-03866 https://www.govinfo.gov/content/pkg/FR-2017-02-28/html/2017-03866.htm https://www.govinfo.gov/content/pkg/FR-2017-02-28/pdf/2017-03866.pdf 2 p. 12067 12068 82 FR 12067 Title 21 Part 2 21 CFR Part 2 RIN 0910-AH36 Use of Ozone-Depleting Substances; Federal Register Vol. 82, Issue RULE 2017-03866 DEPARTMENT OF HEALTH AND HUMAN SERVICES Food and Drug Administration 2017-02-23 Docket No. FDA-2015-N-1355 4164-01-P 2017-03866 Direct final rule; confirmation of effective date.

In accordance with a determination by the Director of the Office of Management and Budget (OMB) that the direct final rule ("Use of Ozone Depleting Substances") published on October 26, 2016, is excluded from the memorandum of January 20, 2017, from the Assistant to the President and Chief of Staff, entitled "Regulatory Freeze Pending Review," this action confirms the effective date of February 23, 2017, for the direct final rule.

The effective date of the direct final rule that published on October 26, 2016, at 81 FR 74298, is confirmed to be February 23, 2017. Daniel Orr, Center for Drug Evaluation and Research, Food and Drug Administration, 10903 New Hampshire Ave., Bldg. 51, Rm. 6246, Silver Spring, MD 20993, 240-402-0979, daniel.orr@fda.hhs.gov. Use of Ozone-Depleting Substances , daniel.orr@fda.hhs.gov Vol. 82, no. 38 Office of the Federal Register, National Archives and Records Administration 2017-02-28 continuing daily deposited born digital 114 p. Table of Contents: AE 2.7: GS 4.107: AE 2.106: KF70.A2 https://www.govinfo.gov/app/details/FR-2017-02-28 P0b002ee193d6559e 0097-6326 0042-1219 0364-1406 769-004-00000-9 000582072 f:fr28fe17 https://www.govinfo.gov/app/details/FR-2017-02-28 https://www.govinfo.gov/content/pkg/FR-2017-02-28/pdf/FR-2017-02-28.pdf https://www.govinfo.gov/content/pkg/FR-2017-02-28/xml/FR-2017-02-28.xml fdlp 12063 12166 DGPO 2017-02-27 2024-06-01 FR-2017-02-28 machine generated eng FR FR-2017-02-28 82 38